Nutex Health

Forecast & Rating5 analysts currently cover Nutex Health, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $288.20, about 35.3% upside from the current price of $213.02. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 53.6% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Nutex Health closely still see room for the stock to rise. Data as of Sep 25, 2026; for reference only and not investment advice.